News release: New Pending Patent with Continuation-In-Part May 2024

  • Home
  • Next Generation Treatment
  • Potential Uses
  • Dr. Brown's Blog
  • About US
  • Contact and License
  • Understand the Market
  • Patient Case Studies
  • Inspect Patents Pending
  • Resources
  • Alzheimer's Research
  • NeoHack News
  • More
    • Home
    • Next Generation Treatment
    • Potential Uses
    • Dr. Brown's Blog
    • About US
    • Contact and License
    • Understand the Market
    • Patient Case Studies
    • Inspect Patents Pending
    • Resources
    • Alzheimer's Research
    • NeoHack News
  • Home
  • Next Generation Treatment
  • Potential Uses
  • Dr. Brown's Blog
  • About US
  • Contact and License
  • Understand the Market
  • Patient Case Studies
  • Inspect Patents Pending
  • Resources
  • Alzheimer's Research
  • NeoHack News

Restoring Homeostasis: The Next Generation

Restoring Homeostasis: The Next Generation Restoring Homeostasis: The Next Generation Restoring Homeostasis: The Next Generation Restoring Homeostasis: The Next Generation

Likely Connections and Potential Uses

Alzheimer's, Dementia

Alzheimer's, Dementia

Alzheimer's, Dementia

Biologic Agent Modifier:

MCP-1, CB2

Likely Synergistic Agents:

Spilantol - MCP-1

Caryophyllene - MCP-1, CB2

Research Indicates:

Research suggests that people with the lowest MCP-1 levels have the least memory loss.  Spilanthol and Caryophyllene are shown to lower MCP-1.




Read the Research

Pain

Alzheimer's, Dementia

Alzheimer's, Dementia

Biologic Agent Modifier:

TRPA1,CB2,Glutathione

Likely Synergistic Agents:

Splilanthol - TRPA1

Caryophyllene - CB2

Dexpanthenol -Glutathione 

Research Indicates: Pain is amplifed by reactive oxygen species "damaging tissues."  Blocking the TRPA1 amplifier will lessen the pain response.  Dexpanthenol increases glutathione which reduces reactive oxygen species and, thus, pain response.


Read the Research

Itch

Alzheimer's, Dementia

Wound Healing

Biologic Agent Modifier:

TRPA1, Keratinocytes, beta-endorphins, histamine/mast cells

Likely Synergistic Agents:

Spilanthol - TRPA1.Beta-endorphins, NFkB

Caryophyllene - Beta-endorphins

Research Indicates: Spilanthol inhibits mast cells from producing histamines which are responsible for typical itch. It also addresses non-histaminergic (neuropathic) itch through NFkB 



Read the Research

Wound Healing

Post Traumatic Stress Disorder

Wound Healing

Biologic Agent Modifier:  

TGF-beta

Likely Synergistic Agents: Spilanthol - TNFa

Research Indicates: Spilanthol is known to reduce TNFa which allows natural TGF-beta to continue wound healing  and, according to Liarte, contributes

to healthy skin homeostasis.




Read the Research

Addictive Behaviors

Post Traumatic Stress Disorder

Post Traumatic Stress Disorder

Biologic Agent Modifier:  

CB2 and mu-opioid

Likely Synergistic Agents: 

Caryophyllene - CB2

Spilanthol - beta endorphin

Research Indicates: 

Addiction reward was subdued in testing on mice, thus reducing addictive behavior.




Read the Research

Post Traumatic Stress Disorder

Post Traumatic Stress Disorder

Post Traumatic Stress Disorder

Biologic Agent Modifier:  

CB2,TRPA1

Likely Synergistic Agents: 

Caryophyllene - CB2

Spilanthol - TRPA1

Research Indicates: 

PTSD brains are known to have elevated inflammation. Caryophyllene and Spilanthol act on inflammation.



Read the Research
Back to Top

Copyright © 2023 NeoHackLife Sciences, LLC - All Rights Reserved


info@neohacksciences.com

Cookie Policy

This website uses cookies. By continuing to use this site, you accept our use of cookies.

Accept & Close